Analysis of methylation in the c‐MYC gene in five human myeloma cell lines

Genomic alterations of the human c‐MYC gene were analysed in five human myeloma cell lines established in Kawasaki Medical School and compared with those of normal lymphocytes, Raji cells from Burkitt's lymphoma, and an Epstein‐Barr virus positive lymphoblastoid cell line (LCL). Although no structural chromosome aberrations at 8q24, the c‐MYC locus, were distinct, the mRNA level of c‐MYC in these myeloma cell lines was 30–50‐fold that in normal peripheral blood lymphocytes. Regarding the methylation of c‐MYC, DNAs of the myeloma cell lines were digested with MspI plus EcoRI or HpaII plus EcoRI, and hybridized with three genomic 32P‐labelled probes; the first, second and third exons of the human c‐MYC gene, respectively. The extent of methylation in cytosine at a single CCGG site in the third exon substantially decreased in these myeloma cell lines as compared with that in normal tonsillar B, LCL and Raji cells. No significant differences in hypomethylation between these myeloma, normal B, LCL and Raji cells was detected in the first and second exon of c‐MVC. These results suggest that the hypomethylation in the third exon of c‐MYC might be related to the enhanced expression of c‐MYC in these human myeloma cell lines.

[1]  T. Sugihara,et al.  Two human myeloma cell lines, amylase‐producing KMS‐12‐PE and amylase‐non‐producing KMS‐12‐BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32) , 1989, British journal of haematology.

[2]  H. Griesser,et al.  Gene rearrangements and translocations in lymphoproliferative diseases , 1989 .

[3]  Yunis Jj,et al.  Mechanisms of ras mutation in myelodysplastic syndrome. , 1989 .

[4]  J. Bos,et al.  Mechanisms of ras mutation in myelodysplastic syndrome. , 1989, Oncogene.

[5]  H. Griesser,et al.  T cell receptor and immunoglobulin gene rearrangements in lymphoproliferative disorders. , 1989, Advances in cancer research.

[6]  F. McCormick,et al.  Analysis of RAS oncogene mutations in human lymphoid malignancies. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Saiki,et al.  Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Gratwohl,et al.  Mutation analysis of the N‐ras proto‐oncogene in active and remission phase of human acute leukemias , 1988, International journal of cancer.

[9]  A. Gazdar,et al.  Complex translocation disrupts c-myc regulation in a human plasma cell myeloma , 1988, Molecular and cellular biology.

[10]  E. Canaani,et al.  Molecular biology of chronic myelogenous leukemia. , 1988, Seminars in hematology.

[11]  G. Mufti,et al.  Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. , 1988, Blood.

[12]  D. Ledbetter,et al.  Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. , 1988, Blood.

[13]  G. Torelli,et al.  Establishment and characterization of a human IgA‐κ‐secreting plasma cell line (MT3) , 1987 .

[14]  H. Mano,et al.  A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome , 1987, Nature.

[15]  J. L. Bos,et al.  Mutations in N-ras predominate in acute myeloid leukemia. , 1987, Blood.

[16]  A. Gazdar,et al.  Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene , 1986 .

[17]  G. Klein,et al.  AMPLIFICATION OF THE C‐MYC ONCOGENE IN HUMAN PLASMA‐CELL LEUKEMIA , 1985, International journal of cancer.

[18]  L. Ratner,et al.  Oncogenes: their role in neoplastic transformation. , 1985, Annual review of microbiology.

[19]  S. Hirohashi,et al.  A novel combination of K‐ras and myc amplification accompanied by point mutational activation of K‐ras in a human lung cancer. , 1984, The EMBO journal.

[20]  R. Hoffman,et al.  Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. , 1984, Journal of the National Cancer Institute.

[21]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[22]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[23]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[24]  G R Stark,et al.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Ikeuchi,et al.  Accumulation of Early Mitotic Cells in Ethidium Bromide-Treated Human Lymphocyte Cultures , 1979 .

[26]  R. Flavell,et al.  MspI, an isoschizomer of hpaII which cleaves both unmethylated and methylated hpaII sites. , 1978, Nucleic acids research.

[27]  H. Boedtker,et al.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. , 1977, Biochemistry.

[28]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.